LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN. EVIDENCE FOR AN INCREASED BONE MASS AFTER DELAYED ONSET OF ŒSTROGEN TREATMENT

The Lancet

Volumn 307, Issue 7968, 1976, Pages 1038-1041

  Lindsay, R ^a   Aitken, J M ^a   Anderson, L B ^a   Hart, D M ^a   Macdonald, E B ^a   Clarke, A C ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; MESTRANOL; PLACEBO;

ARTICLE; BONE; BONE MASS; BONE MINERAL; CALCIUM BLOOD LEVEL; DRUG THERAPY; MENOPAUSE; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PHOSPHATE BLOOD LEVEL; PREVENTION; PROPHYLAXIS; THERAPY;

ADULT; ALKALINE PHOSPHATASE; BONE AND BONES; BONE RESORPTION; BRAIN INJURIES; CALCIUM; CASTRATION; CREATININE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYPROLINE; KIDNEY; MENOPAUSE; MESTRANOL; MIDDLE AGED; OSTEOPOROSIS; PHOSPHATES; POSTOPERATIVE COMPLICATIONS; TIME FACTORS;

EID: 84919592252     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(76)92217-0     Document Type: Article

References (21)

1. Oestrogen Replacement Therapy for Prevention of Osteoporosis after Oophorectomy
2. Preventive Effect of Estrogen on Postmenopausal Bone Loss
3. Thickness and Area Measurements as Parameters of Skeletal Involution of the Humerus, Femur, and Tibia
4. POSTMENOPAUSAL OSTEOPOROSIS
5. Post-menopausal bone loss